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Management of Acute GI Bleeding in Patients Who Refuse Blood or
Blood Products
Abstract
Background and Significance: The Gastroenterology consult service evaluates patients who are admitted to
the hospital with gastrointestinal (GI) tract bleeding. Prompt endoscopic evaluation is the mainstay for the
diagnosis and treatment of clinically significant GI tract bleeding and occurs in concert with the initiation of
supportive measures, including replacement of lost blood, correction of coagulopathy, treatment of
hemorrhagic shock, and stimulation of erythropoiesis. There have been several case reports of patients who
exsanguinated from acute GI tract bleeding due to refusal of blood or blood products on religious grounds.
Management of such patients presents many treatment and ethical challenges. The Jehovah's Witnesses
population literally interprets the Bible passages Genesis 9:4, "But flesh with the life thereof, which is the
blood thereof, shall ye not eat." and Leviticus 17: 15, "And every soul that eateth that which died of itself, or
that which was torn with beasts, whether it be one of your own country, or a stranger, he shall both wash his
clothes, and bathe himself in water, and be unclean until the even: then shall he be clean." to mean that they
should not ingest blood and thus they do not accept blood or blood products. Nonetheless, there are
alternatives, albeit limited, to transfusion of human blood products for patients with acute blood loss
secondary to GI tract bleeding. For example, research studies have demonstrated favorable outcomes
following the use of recombinant factor Vila to treat anemia and achieve hemostasis (Boffard et. Al, 2005). In
addition, as noted by Berend and Levi (2009), there are several unique lessons to be learned from the
management of Jehovah's Witnesses with GI tract bleeding, including learning how to seek and utilize
alternative treatment options, and understand medical views and beliefs of patients from different cultures and
religions. To date, there are no published guidelines that address the management of patients who refuse
transfusion of blood or blood products for faith-based reasons. Purpose: To develop an evidence-based
treatment protocol for the management of patients who refuse transfusion of blood or blood products for
faith-based reasons. Methods: Current evidence was appraised and comparisons were made among the
various treatment options for patients who refuse transfusion of blood or blood products for faith-based
reasons. Using critical appraisal and synthesis, research studies were scored and beneficial interventions from
high-quality studies were incorporated into the evidence-based treatment protocol. Practice
recommendations were then organized into a treatment algorithm. Analyses: The algorithm was critiqued by
an expert review panel and subsequently revised based on its comments and recommendations. The revised
algorithm will be presented to the panel for final approval. Implications: This treatment algorithm will provide
clinicians with an evidence-based guide for the medical management of patients who refuse transfusion of
blood or blood product.
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Evidence Based Protocol: Management of Acute GI Bleeding in Patients Who Refuse Blood 
or Blood Products 
Abstract 
Background and Significance: The Gastroenterology consult service evaluates patients who are 
admitted to the hospital with gastrointestinal (GI) tract bleeding. Prompt endoscopic evaluation 
is the mainstay for the diagnosis and treatment of clinically significant GI tract bleeding and 
occurs in concert with the initiation of supportive measures, including replacement of lost blood, 
correction of coagulopathy, treatment of hemorrhagic shock, and stimulation of erythropoiesis. 
There have been several case reports of patients who exsanguinated from acute GI tract bleeding 
due to refusal of blood or blood products on religious grounds. Management of such patients 
presents many treatment and ethical challenges. 
The Jehovah's Witnesses population literally interprets the Bible passages Genesis 9:4, "But 
flesh with the life thereof, which is the blood thereof, shall ye not eat." and Leviticus 17: 15, 
"And every soul that eateth that which died of itself, or that which was torn with beasts, whether 
it be one of your own country, or a stranger, he shall both wash his clothes, and bathe himself in 
water, and be unclean until the even: then shall he be clean." to mean that they should not ingest 
blood and thus they do not accept blood or blood products. Nonetheless, there are alternatives, 
albeit limited, to transfusion of human blood products for patients with acute blood loss 
secondary to GI tract bleeding. For example, research studies have demonstrated favorable 
outcomes following the use of recombinant factor Vila to treat anemia and achieve hemostasis 
(Boffard et. Al, 2005). In addition, as noted by Berend and Levi (2009), there are several unique 
lessons to be learned from the management of Jehovah's Witnesses with GI tract bleeding, 
including learning how to seek and utilize alternative treatment options, and understand medical 
views and beliefs of patients from different cultures and religions. 
To date, there are no published guidelines that address the management of patients who refuse 
transfusion of blood or blood products for faith-based reasons. 
Purpose: To develop an evidence-based treatment protocol for the management of patients who 
refuse transfusion of blood or blood products for faith-based reasons. 
Methods: Current evidence was appraised and comparisons were made among the various 
treatment options for patients who refuse transfusion of blood or blood products for faith-based 
reasons. Using critical appraisal and synthesis, research studies were scored and beneficial 
interventions from high-quality studies were incorporated into the evidence-based treatment 
protocol. Practice recommendations were then organized into a treatment algorithm. 
Analyses: The algorithm was critiqued by an expert review panel and subsequently revised based 
on its comments and recommendations. The revised algorithm will be presented to the panel for 
final approval. 
Implications: This treatment algorithm will provide clinicians with an evidence-based guide for 
the medical management of patients who refuse transfusion of blood or blood product 
Introduction 
The gastroenterology service at many major medical centers is often consulted when a 
patient presents with gastrointestinal (GI) bleeding. They are responsible for making 
recommendations that affect patient care and outcomes. There have been several reports of 
patients who experienced an episode of acute bleeding from the GI tract (acute GI bleed), that 
have expired because the patient adhered to this faith community's doctrine of refusal of blood 
transfusion. 
This project was developed as a performance improvement project to help improve 
clinical management of patients who refuse transfusion of blood or blood products for faith-
based reasons. An evidence-based treatment algorithm was developed using the most current 
information to ensure that clinicians manage this patient population consistently and 
appropriately, and that every treatment option and alternative is presented to patients. This 
treatment algorithm will be used as a reference for providers on the gastroenterology service to 
employ best practice during consultations involving treatment recommendations for this complex 
patient population. 
Jehovah's Witnesses are a group of individuals who began as a Bible study group in 
1869. Part of the charge of their Bible study group was to extensively analyze various Biblical 
readings. They found what they characterized as multiple errors in the traditional Christian 
doctrine, including those related to Christian teachings. Thus, the religious convictions of this 
following were based on strict literal interpretation of the Bible. In 1931, they adopted the name 
Jehovah's Witnesses, which is based on Isaiah 43:10-12. There are over 6.7 million members 
currently worldwide (Huges, Ullery, & Barie, 2008). 
The Jehovah's Witnesses literally interpreted the following Biblical passages: "The one 
thing you must not eat is meat with blood still in it; I forbid this because the life is in the blood" 
(Genesis 9:4) and "The life of every living thing is in blood, and that is why the LORD has told 
people of Israel that they shall not eat any meat with blood still in it and that anyone who does so 
will no longer be considered one of his people" (Leviticus 17: 15). These passages explain and 
provide rationale for why this population refuses blood and blood products. The people of the 
Jehovah's Witness faith community are permitted to make the decision based on their own 
conscious thought, but if they do decide to accept blood or blood products, there is a formal 
process of "de-fellowship" that is instituted by the church itself (Effa-Heap, 2009). When taking 
responsibility for the care of a Jehovah's Witness patient, it is important for clinicians to 
understand why they feel so strongly about this issue. Consequently, as providers, we should 
present to them all of the treatment options available and respect the choices that they make. 
Boffard et. al (2005) conducted two parallel randomized, placebo-controlled, double-
blind clinical trials. The investigators used recombinant factor VIIa as adjunctive therapy for 
bleeding control in severely injured trauma patients. Red blood cell (RBC) transfusion was 
significantly reduced with rFVIIa relative to placebo and the need for massive transfusion. In 
penetrating trauma, similar analyses showed trends toward rFVIIa reducing RBC transfusion and 
massive transfusion. Mortality rate and critical complications also were reduced. These findings 
provide evidence for the use of rFVIIa in the reduction of RBC transfusion in severe blunt 
trauma (Boffard, et. Al., 2005). 
The use of Recombinant Factor VIIa ( rFVIIa) was also supported via two case reports 
regarding treatment of excessive bleeding in Jehovah's Witness patients following cardiac 
surgery (Tanaka, Waly, Cooper, & Levy, 2003). Findings revealed that hemostasis (cessation of 
bleeding) was improved in a cardiac surgical patient who refused blood products. Because no 
human protein or derivatives were present during the manufacturing or purification process of 
recombinant factor VIIa in baby hamster kidney cells, rFVIIa was found to be an acceptable 
treatment option for these patients. These case reports provide further evidence on alternative 
therapeutic options for this patient population. 
The Jehovah's Witness patient population may be very challenging to clinically manage 
because they refuse mainstream treatment options even at times when they face a life or death 
choice. Berend and Levi (2009) noted that there are lessons to be learned from the management 
of Jehovah's Witnesses, including acquisition of skills to seek alternatives to obvious treatments, 
and seeking to understand views and beliefs of patients from different cultures. Having a tool in 
a medical decision tree format to guide treatment of these patients will help providers stay 
focused and consistent in their approach. 
The purpose of this Performance Improvement project was to develop an evidence-based 
treatment protocol to clinically manage patients who refuse transfusion of blood or blood 
products for faith-based reasons. 
Methods 
An extensive updated review of literature was conducted through online databases using the 
University of Rochester Medical Center Miner Library and St. John Fisher College Lavery 
Library online resources. Further assistance was requested, as needed, from a dedicated health 
studies librarian, at Lavery Library, St. John Fisher College. 
Current evidence was appraised and comparisons were made among the various management 
options for patient who refuse transfusion of blood or blood products for faith-based reasons. 
Using the techniques of critical appraisal and synthesis, literature was scored and decisions were 
made whether to incorporate resulting research evidence into the new evidence-based treatment 
protocol. 
Research gathered during the literature search was organized into an algorithm type flow 
chart. This algorithm will be available to give providers a decision tree approach to medical 
management of a patient who refuses transfusion of blood or blood products. The evidence 
based protocol was then critiqued by expert review including one gastroenterology Attending, 
one gastroenterology Fellow and two Advanced Practice Registered Nurses. They were asked to 
critique the protocol for usability, adherence to current practice guidelines and compliance with 
provider scope recommendations. 
Outcomes 
Listed below are the questions asked during the review process, 
I. Does this protocol follow current practice guidelines? 
2. Does it seem practical for use when treating this patient population? 
3. Could this protocol be used by Fellows, Residents, NP/CNS's, PA's? 
4. Recommended changes 
5. Comments 
All of the expert reviewers felt this performance improvement project will be essential 
for treating this patient population. They stated that the recommendations follow current 
evidence, it was easy to use and could be used across the interdisciplinary team. One of the 
APRN reviewers stated "This shows the many things we still have available in our toolbox.", "I 
would add this to my clinical pearls." The experts had minor spelling and layout 
recommendations. 
One of the APRN reviewers stated "I think that this protocol has the potential to provide 
us with alternatives for the management of patient's with gastrointestinal bleeds that are 
Jehovah's witnesses, but also helps us to find alternatives to blood products when there is such a 
significant shortage of blood products available for all of our patients". This protocol is intended 
for use by any provider that comes in contact with the situation that their patient refuses blood 
transfusions. It is meant to give providers ideas of ways to manage this patient population and it 
could most certainly be used when there is a shortage of blood products available to make sure 
we are using all of the current evidence to treat the patients. 
Changes 
One of the changes that were made in tlie protocol was contacting the Jehovah's Witness 
liaison committee. The literature had recommended contacting a member of this committee to 
give providers support during management of this patient. The inclusion of the liaison committee 
contact would be beneficial in maintaining an open relationship with the patient and the 
providers. It would demonstrate that health care providers were taking all of the necessary steps 
to ensure cultural competence. This protocol was developed for use in any department treating a 
population who refuses blood or blood products. Many hospitals may not have a Jehovah's 
Witness liaison committee. This may add more confusion to the protocol. Another performance 
improvement project should be considered to develop a Jehovah's Witness Liaison committee. 
This would serve as a great resource for any community so that this patient population feels 
comfortable being treated at different medical facilities. 
Discussion 
When developing a protocol it is also important to think about possible barriers to 
implementation. The APRN reviewer discussed possible barriers to implementing this protocol 
which included the availability of the gastroenterology staff to be able to perform the procedures 
in an expedited fashion, the availability of the closed circuit blood salvage equipment and the 
overall willingness of the patient to accept the treatment plan and provide consent. Most large 
medical facilities have an on-call gastroenterology service. For emergency procedures the 
endoscopy team must respond to cases within one hour. The use of the closed circuit blood 
salvage equipment was removed from the protocol. The protocol is developed to assist a provider 
in initiating care when they are faced with the new patient situation. Using the closed circuit 
blood salvage equipment would require surgical consult, more research of literature and a more 
in-depth protocol. The development of an additional protocol utilizing the closed circuit blood 
salvage equipment separate from this protocol may be helpful. 
It is crucial that health care providers develop a trusting relationship with their health care 
providers. With trusting professional relationships, patients may be more likely to actively 
participate in the health care recommendations offered. Providers with background knowledge 
about this specific patient population will be able to discuss treatment options that follow the 
patient's religious practices. 
Recommendations 
Based on expert review this protocol is easy to use and it should be used across the 
interdisciplinary team for the treatment of this patient population. The protocol follows current 
evidence and recommended practice guidelines. This protocol could be disseminated to the 
gastroenterology service at any major medical center. This would also be useful in emergency 
. 
department care, where care for hypovolemic shock from bleeding is most frequently initiated. 
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Early 
transfer to 
capable 
hospital 
Consider GI +/-
Hematology 
consult while 
awaiting 
transfer 
Page the GI Fellow on call 
Consider Hematology Consultation 
Determine if ICU level of care is needed 
Prompt arrest 
of bleeding 
>Endoscopy 
>Antifibrinolytics (aminocaproic 
acid or tranexamic acid) 
>Tolerate hypotension (SBP>85) 
>PPI drip 
>Octreotide drip (if concern 
for varicies) 
>Conservative use of 
moderately warm IV fluid 
for hypotension 
>Maximize oxygenation 
>Vasopressors 
Immediate treatment 
Stimulate 
Erythro-
poiesis 
>Erythropoietin 
>Iron 
>Folic Acid 
>Vit B12 
>Recombinant 
factor VIia 
Supportive 
Measures 
>Limit diagnostic phlebotomy 
(use pediatric vaccutianer 
tube if available) 
>Decrease metabolic rate 
(maintain normothermia, 
control rigors, treat agitation) 
Recurrent or ongoing hemorrhage 
Recurrent hemorrhage 
>Discuss reconsidering blood 
transfusion with patient 
>Repeat emergent endoscopy or 
colonoscopy 
Hemostasis Achieved 
>Close observation 
>Continue IV PPI drip if peptic 
ulcer hemorrhage 
>+/- octreotide drip 
Hemostasis Not Achieved 
Ongoing hemorrhage 
>+/-Tagged RBC scan 
>IR consultation for angiography with 
selective embolization 
>Surgical consultation for refractory 
bleeding 
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